Over time, investment in healthcare can ensure a healthier older generation that is more productive and requires less care
Authorities are rushing to contain latest outbreak fuelled by a more dangerous type of the virus
Administration claims victory in talks to cut the costs of 10 critical medicines
The Food and Drug Administration’s rejection of MDMA-assisted therapy is a missed opportunity
Global health body calls for action to tackle ‘very worrying’ outbreak of highly transmissible virus
Pharma groups and patients say guidance prioritising mass trials threaten drug development
Nice’s backing for Casgevy comes after UK became first country to give drug regulatory approval
Improvements to data infrastructure are needed if AI is to help fix the UK national health service
For years, the process for developing and testing new drugs has focused disproportionately on male bodies — to the detriment of female patients
Huge rise in prescriptions for women aged 25 to 34 in England driven by social media highlighting symptoms
Extreme shortages of actinium are holding up the promising field of radiopharmaceuticals
Care Quality Commission’s shortcomings are ‘hampering’ its ability to identify poor performance, says independent review
Long waiting list for drug because of shortage of specialist services could hit patients unable to pay privately
Large gifts aim to boost diversity and career options amid rising costs for training doctors
Shares are down 70% for the world’s largest maker of insulin pen needles and syringes since it was spun off
Swiss drugmaker says it will only sell medication privately if health systems cannot pay
There is concern that medications used widely for weight loss have not been tested for use by pregnant women
Lessons from other countries highlight importance of political consensus to fix chronic funding shortfall
Health services in comparable countries have recovered faster than England, study finds
US-listed pharmacy group’s problems have been exacerbated by its struggle to move into healthcare
Poor west African nation struggles with surge in use of toxic ‘kush’
Ageing is a long-term trend that investors can bank on
A spinout of the medtech’s orthopaedics business would unlock value while shifting to the US could also deliver gains
Shares in London-listed maker of medical devices jump as holdings disclosed
Sale of most of FairJourney Biologics means London-based owner GHO Capital realises close to 10-fold return
